Concepedia

Silvia Martin Lluesma

SM

5

Publications

759

Citations

5

H-Index

2002

Active since

Affiliations

SIB Swiss Institute of Bioinformatics(Current)

University of Lausanne

Ludwig Cancer Research

University Hospital of Lausanne

Silvia Martin Lluesma is an author at SIB Swiss Institute of Bioinformatics specializing in medicine, cell signaling, and precision vaccinology.

ORCID

Top concepts

Publications per year

2002–2019

5

Publications

5

Role of Hec1 in Spindle Checkpoint Signaling and Kinetochore Recruitment of Mad1/Mad2

Silvia Martin Lluesma, Volker M. Stucke, Erich A. Nigg · Science · 2002 · 426 citations

, , +18

Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1

Silvia Martin Lluesma, Céline Schaeffer, Eva Isabelle Robert et al. · Hepatology · 2008 · 102 citations · Full text

Recombinant Antibodies Against Subcellular Fractions Used to Track Endogenous Golgi Protein Dynamics <i>in Vivo</i>

Clément Nizak, Silvia Martin Lluesma, Sandrine Moutel et al. · Traffic · 2003 · 99 citations

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients

Michal Bassani‐Sternberg, Antonia Digklia, Florian Huber et al. · Frontiers in Immunology · 2019 · 73 citations · Full text

, , +22

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma

Apostolos Sarivalasis, Caroline Boudousquié, Klara Balint et al. · Journal of Translational Medicine · 2019 · 59 citations · Full text

Rows per page

1–5 of 5